2023
DOI: 10.1021/acs.accounts.3c00585
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Recognition with Macrocyclic Receptors for Application in Precision Medicine

Yu-Chen Pan,
Jia-Hong Tian,
Dong-Sheng Guo
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
7
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
9

Relationship

4
5

Authors

Journals

citations
Cited by 25 publications
(7 citation statements)
references
References 79 publications
0
7
0
Order By: Relevance
“…These macrocyclic carriers boast well-defined nanosized structures, utilizing their preorganized cavities for equivalent loading and encapsulation of drug molecules. Moreover, they can achieve controlled drug release by incorporating a suitable stimulus-responsiveness. For example, our previously developed macrocyclic carriers based on azocalixarenes have demonstrated not only strong binding affinities but also hypoxia-triggered release for various drugs, rendering them to be a versatile platform for the treatment of many hypoxia-related diseases. Besides, the exclusive formation of an intramolecular self-included complex, rather than an intermolecular supramolecular polymer or assembly, can be achieved by selecting an appropriately sized covalent spacer to connect a macrocyclic carrier with its guest, such as a drug molecules. Owing to the concentration-independent nature of intramolecular encapsulation, it can effectively prevent off-target leakage of drugs during in vivo circulation. , Therefore, the unique intramolecular inclusion feature of SMNMs not only effectively encapsulates and protects drugs but also prevents off-target leakage, thereby significantly enhancing the stability of drugs in complex physiological environments and reducing drug side effects. Additionally, the characteristics of being a single component and molecularly dispersed confer advantages, such as ease of preparation and good reproducibility.…”
Section: Introductionmentioning
confidence: 99%
“…These macrocyclic carriers boast well-defined nanosized structures, utilizing their preorganized cavities for equivalent loading and encapsulation of drug molecules. Moreover, they can achieve controlled drug release by incorporating a suitable stimulus-responsiveness. For example, our previously developed macrocyclic carriers based on azocalixarenes have demonstrated not only strong binding affinities but also hypoxia-triggered release for various drugs, rendering them to be a versatile platform for the treatment of many hypoxia-related diseases. Besides, the exclusive formation of an intramolecular self-included complex, rather than an intermolecular supramolecular polymer or assembly, can be achieved by selecting an appropriately sized covalent spacer to connect a macrocyclic carrier with its guest, such as a drug molecules. Owing to the concentration-independent nature of intramolecular encapsulation, it can effectively prevent off-target leakage of drugs during in vivo circulation. , Therefore, the unique intramolecular inclusion feature of SMNMs not only effectively encapsulates and protects drugs but also prevents off-target leakage, thereby significantly enhancing the stability of drugs in complex physiological environments and reducing drug side effects. Additionally, the characteristics of being a single component and molecularly dispersed confer advantages, such as ease of preparation and good reproducibility.…”
Section: Introductionmentioning
confidence: 99%
“…Calix [4]arenes are macrocyclic compounds formed by condensation of four molecules of phenol and four molecules of formaldehyde, which, after adequate functionalization, could be used as building blocks for applications in host-guest chemistry, coordination chemistry, homogeneous catalysis, and materials or medicinal sciences [1][2][3][4][5][6][7][8][9][10][11][12].…”
Section: Introductionmentioning
confidence: 99%
“…Synthesis of {25,26,27-Tribenzoyl-28-[((S)-1-diphenylphosphanyl-propan-2-yl)oxy]-calix[4] arene} borane (1,3-alternate)(8) …”
mentioning
confidence: 99%
“…4 The Guo group has used azo-calixarene derivatives for numerous applications including hypoxia imaging. 5 Our group has demonstrated the use of CB[ n ]-type receptors – with their ultratight binding properties 2 d – as in vivo sequestrants to counteract the effects of a variety of biologically active substances. 6 Perhaps the most stunning real-world application of a macrocyclic host is the clinical use of the γ-cyclodextrin derivative sugammadex to alleviate the post-surgical side effects of the neuromuscular blocking agents (NMBA) rocuronium (roc) and vecuronium (vec).…”
mentioning
confidence: 99%